HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.

Abstract

As a single marker, HE4 had the highest sensitivity for detecting ovarian carcinoma specially early stage disease. Combined CA125 and HE4 was a more accurate predictor of ovarian malignancy than either alone.